Prof. Francesco Del Galdo
Head of Scleroderma Programme at NIHR Biomedical Research Centre and Honorary Consultant Rheumatologist at Leeds Teaching Hospital Trusts, UK
United Kingdom
Areas of expertise
- Scleroderma (Systemic Sclerosis)
- Raynaud's disease
- Fibromyalgia
- Dermatomyositis
- Sjogren's syndrome
- Lupus
- Vasculitis
- Osteoarthritis
- Connective tissue diseases
About the expert
Prof. Francesco Del Galdo, a leading rheumatologist, delves deep into the mysteries of Scleroderma (Systemic Sclerosis). He boasts an impressive academic background and research expertise, evident in his publications and leadership roles in prestigious journals and organizations. His dedication to advancing the field extends beyond research, as he actively mentors students and shares knowledge through lectures and conferences. His ongoing efforts illuminate the path towards better understanding and managing complex diseases, contributing to improved patient outcomes.
Professor Francesco Del Galdo is an accomplished medical professional and researcher specializing in rheumatology and experimental medicine. He currently holds the position of Professor of Experimental Medicine at the University of Leeds and serves as the Head of the Scleroderma Programme at the NIHR Leeds Biomedical Research Centre. Prof. Del Galdo expertise extends to more than 20 years.
With a strong academic background, he obtained his Medical Doctor's Degree and Clinical Specialty Training in Immunology from the Second University of Naples, Italy. He further pursued his academic pursuits by completing a PhD on early events in the pathogenesis of Systemic Sclerosis at Thomas Jefferson University in Philadelphia, USA, and the Second University of Naples, Italy.
Throughout his career, Professor Del Galdo has made significant contributions to the field of rheumatology. He has served on the editorial boards of prestigious scientific journals such as the "American Journal of Pathology" and the "Journal of Scleroderma and Related Disorders." He is also a member of various scientific boards and committees, including the EUSTAR Scientific Board, the World Scleroderma Foundation Scientific Advisory Board, and the Scleroderma Clinical Trials Consortium.
He has been actively involved in clinical trials and research projects related to systemic sclerosis and other rheumatological conditions. He has served as the Chief Investigator for the Stratification for Risk of Progression in Scleroderma (STRIKE SSC) trial and has also been involved as the Site Principal Investigator for several completed clinical trials. His research endeavors have been supported by prestigious funding bodies and foundations, including the Kennedy Trust for Rheumatology Research, the National Institute for Health Research (NIHR), and various research grants.
Additionally, Professor Del Galdo is dedicated to sharing his knowledge and expertise through teaching and lecturing. He has been involved in undergraduate and postgraduate teaching, delivering lectures, and providing CPD (Continuing Professional Development) training to consultants and specialty registrars. He has also been invited to speak at national and international conferences, contributing to the dissemination of advancements in systemic sclerosis and the management of related medical conditions.
With an impressive publication record in international peer-reviewed journals and a notable h-index, Professor Del Galdo's research findings and contributions have been widely recognized and cited within the scientific community. He continues to make significant strides in understanding the pathogenesis of systemic sclerosis and improving the clinical outcomes for patients with this challenging condition.
-
Professor of Experimental Medicine
2021 - TodayUniversity of Leeds
-
Head, Scleroderma Programme
2014 - TodayNIHR Biomedical Research Centre, UK
-
Honorary Consultant Rheumatologist
2014 - TodayLeeds Teaching Hospital Trusts
-
Associate Professor
2014 - 2021University of Leeds, UK
-
Senior Clinical Lecturer / Senior Translational Research Fellow
2009 - 2014University of Leeds, UK
-
PhD
Thomas Jefferson University, Philadelphia, USA / Second University of Naples, Italy
2007
-
Clinical Specialty Training in Immunology
Second University of Naples, Italy
2003
-
President of European Scleroderma Trials and Research Group (EUSTAR) (2022)
-
Chair of Scientific Board of World Scleroderma Congress (2021)
-
National Theme Lead for NIHR Musculoskeletal Health Informatic Cooperative (2018)
-
Clinical and Academic lead for IT, Leeds NIHR Biomedical Research Centre (2017)
-
Editorial board Member for “Journal of Scleroderma and Related disorders” (2016)
-
Scleroderma Clinical Trials Consortium - Centre Lead (2014)
-
World Scleroderma Foundation – Scientific Advisory board member (2012)
Other experts inthe same speciality
Dr. Alvin F. Wells
Attending Rheumatologist, Director of the Rheumatology and Immunotherapy Center in Franklin, WI, USA.
More about the expert
Dr. Eslam Al-Abadi
Consultant Paediatric Rheumatologist, Birmingham Children’s Hospital, Birmingham, UK.
More about the expert
Dr. Elena Nikiphorou
Consultant Rheumatologist at The London Clinic and King's College Hospital, London, UK
More about the expert
Dr. Ozlem Pala
Assistant Professor of Clinical Medicine, Miller School of Medicine at the University of Miami, Miami, FL, USA
More about the expert
Prof. Chokkalingam Siva
Professor of Clinical Medicine and Program Director of Rheumatology Fellowship Program at University of Missouri School of Medicine, USA
More about the expert
Our network includes more than 1000 international experts in more than 1200 specialities and sub-specialities
See experts in all specialities